Please use this identifier to cite or link to this item:
Title: Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause
Authors: Sze, Stephen Cho Wing
Cheung, Ho-pan
Ng, Tzi-bun
Zhang, Zhang-jing
Wong, Kam-lok
Wong, Hei-kiu
Hu, Yong-mei
Yow, Christine Miu-ngan
Tong, Yao
Issue Date: 2-Nov-2011
Publisher: BioMed Central Ltd.
Source: Chinese medicine, 2 Nov. 2011, v. 6, no. 40, p. 1-10.
Abstract: Background: The prevalence and risk of cardiovascular disease increase after menopause in correlation with the progression of abnormality in the serum lipid profile and the deprivation of estrogen. Erxian decoction (EXD), a Chinese medicinal formulation for treating menopausal syndrome, stimulates ovarian estrogen biosynthesis. This study investigates whether EXD improves the serum lipid profile in a menopausal rat model.
Methods: Twenty-month-old female Sprague Dawley rats were treated with EXD and its constituent fractions. Premarin was administered for comparison. After eight weeks of treatment, rats were sacrificed and the serum levels of total cholesterol, triglyceride, high-density-lipoprotein cholesterol and low-density-lipoprotein cholesterol were determined. The hepatic protein levels of 3-hydroxy-3-methyl-glutaryl-CoA reductase and low-densitylipoprotein receptor were assessed with Western blot.
Results: The serum levels of total cholesterol and low-density-lipoprotein cholesterol were significantly lower in the EXD-treated group than in the constituent fractions of EXD or premarin groups. However, the serum levels of triglyceride and high-density-lipoprotein cholesterol were not significantly different from the control groups. Results from Western blot suggest that EXD significantly down-regulated the protein level of 3-hydroxy-3-methyl-glutaryl- CoA reductase and up-regulated low-density-lipoprotein receptor. Conclusion EXD improves serum lipid profile in a menopausal rat model through the suppression of the serum levels of total cholesterol and low-densitylipoprotein cholesterol, possibly through the down-regulation of the 3-hydroxy-3-methyl-glutaryl-CoA and up-regulation of the low-density-lipoprotein receptor.
Rights: © 2011 Sze et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Type: Journal/Magazine Article
DOI: 10.1186/1749-8546-6-40
ISSN: 1749-8546
Appears in Collections:HTI Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
Sze_Effects_Erxian_decoction.pdf782.87 kBAdobe PDFView/Open

All items in the PolyU Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated. No item in the PolyU IR may be reproduced for commercial or resale purposes.